LONGLIFE PROSTAFACTORS 60 CAPSULES

  • PHOENIX Srl - LONGLIFE
  • 906604347
  • 8054521002069

Food supplement based on natural extracts.

- Antioxidant action.

-Based on serenoa repens.

info_outline View product sheet
Final Price €20.32
Regular Price €23.90
Save 15%
Quantity
check_circle Available (12 Items)
48h
  Convenient and safe payments

Even with a credit card

  Shipping in 48h-72h all over the world

FREE in Italy over € 39.90

  Fast returns and 14 days to reconsider

14 days to reconsider

  90 years of pharmaceutical experience at your service

Always at your service

Supplements Others products at unbeatable price

PHOENIX Srl - LONGLIFE

Discover all products

LONGLIFE PROSTAFACTORS 60 CAPSULES

LongLife
ProstaFactors

Description
Food supplement of serenoa titrated at 90% in free fatty acids, with pumpkin seed oil, useful for promoting the well-being and functionality of the prostate, for the drainage of body fluids and for the functionality of the urinary tract.

Ingredients
Lecithin of soy, serenoa fruit, pumpkin seed oil, gelatin capsule.
Contains soy.

Without gluten.

Nutritional characteristics
Average values For 2 capsules
Soy lecithin
titled 62% phospholipids
360 mg
223 mg
Serenoa fruit
titrated fat-soluble extract
90% free fatty acids
0.2% beta-sitosterol
320 mg

288 mg
0.640 mg
Pumpkin seed oil 320 mg

How to use
Swallow one (1) capsule twice daily with water with meals.

Warnings
Food supplements are not intended as a substitute for a varied diet and should be used following a healthy and balanced lifestyle. Do not exceed the recommended daily dose. Keep out of the reach of children under three years of age. It is not recommended for use in women of childbearing age and in prepubescent subjects of both sexes.

storage
Keep in a cold and dry place.
Validity for intact packaging: 36 months.

Format
Jar of 60 capsules of 0,600 g.
Net weight: 36 g.

Cod. 0179

Bibliography
-Wilt T, Ishani A, Mac Donald R. Serenoa repens for benign prostatic hyperplasia. [Review]. Cochrane Database of Systematic Reviews 2008 Issue 1.
-Drsata J. Enzyme inhibition in the drug therapy of benign prostatic hyperplasia. Cas Lek Cesk 2002 Oct 11; 141 (20): 630-5.
906604347
12 Items